Paraguay’s president survives impeachment bid over pandemic

Recent days have seen a series of protests against Abdo's government amid overwhelmed hospitals and shortages of vaccines and drugs for COVID-19 patients.

Asuncion: President Mario Abdo Benítez survived an opposition attempt in Paraguay’s congress to impeach him on Wednesday over his handling of the coronavirus pandemic, while hundreds protested outside the legislature demanding his resignation.

The Chamber of Deputies, which is dominated by his governing Colorado Party, voted 42 to 36 to reject impeachment.

---

Outside, hundreds of protesters threw stones at police who responded with water cannons and rubber bullets. Some protesters smashed store windows and car windshields, while shouting anti-Abdo slogans. Several people were arrested.

Recent days have seen a series of protests against Abdo’s government amid overwhelmed hospitals and shortages of vaccines and drugs for COVID-19 patients. The shortages prompted Wednesday’s bid by the opposition to remove him from office.

Some doctors and nurses have joined the protests.

“It was time for Abdo Benitez and his entire government to leave office because they did nothing to confront the coronavirus. There are no vaccines, there are no drugs in hospitals, and the hospital infrastructure is deficient,” Kattya Gonzalez, a legislator with opposition group Encuentro Nacional, said at a news conference.

More than 183,000 confirmed coronavirus cases and 3,554 deaths related to COVID-19 have been registered in the South American country of 7.6 million people.

Opposition lawmakers emphasised, among other things, that so far only 24,000 vaccine doses have arrived in Paraguay.

Abdo Benítez has not commented publicly on the impeachment bid. But the leader of pro-government lawmakers, Basilio Nunez, said it “was impossible for the opposition to impeach the president because the effort clearly has electoral objectives,” alluding to the municipal elections scheduled for October and national elections set for May 2023.